385 related articles for article (PubMed ID: 16091896)
21. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
[TBL] [Abstract][Full Text] [Related]
22. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia.
Boussekey N; Leroy O; Alfandari S; Devos P; Georges H; Guery B
Intensive Care Med; 2006 Mar; 32(3):469-72. PubMed ID: 16477418
[TBL] [Abstract][Full Text] [Related]
23. [Changes in plasma interleukin-33 concentration in sepsis and its correlation with seriousness of sepsis].
Chang D; Jia J; Zang B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):138-42. PubMed ID: 25665614
[TBL] [Abstract][Full Text] [Related]
24. Serum procalcitonin is a sensitive marker for septic shock and mortality in secondary peritonitis.
Pupelis G; Drozdova N; Mukans M; Malbrain ML
Anaesthesiol Intensive Ther; 2014; 46(4):262-73. PubMed ID: 25293477
[TBL] [Abstract][Full Text] [Related]
25. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock.
Clec'h C; Fosse JP; Karoubi P; Vincent F; Chouahi I; Hamza L; Cupa M; Cohen Y
Crit Care Med; 2006 Jan; 34(1):102-7. PubMed ID: 16374163
[TBL] [Abstract][Full Text] [Related]
26. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma.
Castelli GP; Pognani C; Cita M; Paladini R
Crit Care Med; 2009 Jun; 37(6):1845-9. PubMed ID: 19384224
[TBL] [Abstract][Full Text] [Related]
27. The utility of initial procalcitonin and procalcitonin clearance for prediction of bacterial infection and outcome in critically ill patients with autoimmune diseases: a prospective observational study.
Shi Y; Peng JM; Hu XY; Wang Y
BMC Anesthesiol; 2015 Oct; 15():137. PubMed ID: 26446077
[TBL] [Abstract][Full Text] [Related]
28. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
[TBL] [Abstract][Full Text] [Related]
30. Serial quantification of procalcitonin (PCT) predicts clinical outcome and prognosis in patients with community-acquired pneumonia (CAP).
Tamura M; Watanabe M; Nakajima A; Kurai D; Ishii H; Takata S; Nakamoto K; Sohara E; Honda K; Nakamura M; Inui T; Wada H; Takizawa H; Goto H
J Infect Chemother; 2014 Feb; 20(2):97-103. PubMed ID: 24462441
[TBL] [Abstract][Full Text] [Related]
31. [Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia].
Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Parejo Miguez R; Flores Chacartegui M; Gallardo Schall P
Med Clin (Barc); 2014 Apr; 142(7):285-92. PubMed ID: 24120103
[TBL] [Abstract][Full Text] [Related]
32. Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis.
Kocazeybek B; Küçükoğlu S; Oner YA
Chemotherapy; 2003 May; 49(1-2):76-84. PubMed ID: 12714816
[TBL] [Abstract][Full Text] [Related]
33. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock.
Hatherill M; Tibby SM; Turner C; Ratnavel N; Murdoch IA
Crit Care Med; 2000 Jul; 28(7):2591-4. PubMed ID: 10921600
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and laboratory criteria for identification of early-onset stroke associated pneumonia: a prospective trial].
Xie J; Lu YM; Long W; He MZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jan; 23(1):24-7. PubMed ID: 21251362
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.
Ramírez P; Ferrer M; Martí V; Reyes S; Martínez R; Menéndez R; Ewig S; Torres A
Crit Care Med; 2011 Oct; 39(10):2211-7. PubMed ID: 21705887
[TBL] [Abstract][Full Text] [Related]
36. Clinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic Shock.
Ryu JA; Yang JH; Lee D; Park CM; Suh GY; Jeon K; Cho J; Baek SY; Carriere KC; Chung CR
PLoS One; 2015; 10(9):e0138150. PubMed ID: 26367532
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management.
Que YA; Delodder F; Guessous I; Graf R; Bain M; Calandra T; Liaudet L; Eggimann P
Crit Care; 2012 Jul; 16(4):R114. PubMed ID: 22748193
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
[TBL] [Abstract][Full Text] [Related]
39. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.
Kang YA; Kwon SY; Yoon HI; Lee JH; Lee CT
Korean J Intern Med; 2009 Dec; 24(4):337-42. PubMed ID: 19949732
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic value of serum procalcitonin for infection in the immunocompromised critically ill patients with suspected infection].
Yu X; Ma X; Ai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):477-83. PubMed ID: 26049187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
